Akebia Therapeutics, Inc. (AKBA) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 53.54M | 57.62M | 58.77M | 62.47M | 57.34M | 46.5M | 37.43M | 43.65M | 32.61M | 56.2M | 42.05M | 56.38M | 40.01M | 55.18M | 48.71M | 126.36M | 61.7M | 57.68M | 48.76M | 52.91M |
| Revenue Growth % | -6.61% | 23.92% | 57.01% | 43.13% | 75.84% | -17.26% | -10.98% | -22.58% | -18.49% | 1.84% | -13.69% | -55.39% | -35.16% | -4.33% | -0.09% | 138.82% | 17.96% | 1.72% | -18.72% | -41.3% |
| Cost of Goods Sold | 12.62M | 12.22M | 9.7M | 9.92M | 7.63M | 20.36M | 14.16M | 8.3M | 2.71M | 18.66M | 18.01M | 17.28M | 20.19M | -3.1M | 38.28M | 18.6M | 31.34M | 31.72M | 15.94M | 52.49M |
| COGS % of Revenue | 23.57% | 21.2% | 16.51% | 15.88% | 13.3% | 43.8% | 37.84% | 19.01% | 8.33% | 33.21% | 42.83% | 30.66% | 50.47% | -5.61% | 78.58% | 14.72% | 50.8% | 55% | 32.7% | 99.21% |
| Gross Profit | 40.93M | 45.41M | 49.06M | 52.55M | 49.71M | 26.13M | 23.27M | 35.35M | 29.89M | 37.53M | 24.04M | 39.09M | 19.82M | 58.27M | 10.43M | 107.77M | 30.36M | 25.95M | 32.81M | 418K |
| Gross Margin % | 76.43% | 78.8% | 83.49% | 84.12% | 86.7% | 56.2% | 62.16% | 80.99% | 91.67% | 66.79% | 57.17% | 69.34% | 49.53% | 105.61% | 21.42% | 85.28% | 49.2% | 45% | 67.3% | 0.79% |
| Gross Profit Growth % | -17.67% | 73.75% | 110.88% | 48.66% | 66.3% | -30.37% | -3.2% | -9.57% | 50.85% | -35.6% | 130.39% | -63.72% | -34.72% | 124.53% | -68.2% | 25681.1% | 71.52% | -13.13% | 10.69% | 100.49% |
| Operating Expenses | 45.62M | 53.96M | 44.62M | 38.46M | 36.2M | 40.44M | 35.77M | 44.08M | 44.83M | 36.16M | 37.07M | 48.09M | 45.41M | 64.63M | 60.84M | 73.69M | 88.85M | 91.29M | 87.7M | 79.76M |
| OpEx % of Revenue | 85.2% | 93.64% | 75.92% | 61.57% | 63.13% | 86.97% | 95.58% | 100.98% | 137.48% | 64.34% | 88.17% | 85.3% | 113.52% | 117.12% | 124.89% | 58.32% | 144% | 158.28% | 179.87% | 150.74% |
| Selling, General & Admin | 30.44M | 26.09M | 29.99M | 26.55M | 25.74M | 27.68M | 26.52M | 0 | 0 | 25.44M | 22.71M | 27.04M | 25.05M | 30.65M | 31.89M | 32.24M | 44.33M | 44.8M | 46.36M | 42.55M |
| SG&A % of Revenue | 56.84% | 45.28% | 51.03% | 42.51% | 44.9% | 59.52% | 70.85% | - | - | 45.26% | 54.01% | 47.96% | 62.62% | 55.54% | 65.46% | 25.51% | 71.84% | 77.68% | 95.08% | 80.41% |
| Research & Development | 14.81M | 26.65M | 14.63M | 11.01M | 9.75M | 11.79M | 8.49M | 7.65M | 9.73M | 9.87M | 13.33M | 20.2M | 19.69M | 31.9M | 28.03M | 26.03M | 43.83M | 29.56M | 40.47M | 37.21M |
| R&D % of Revenue | 27.65% | 46.25% | 24.89% | 17.63% | 17.01% | 25.35% | 22.68% | 17.52% | 29.84% | 17.55% | 31.7% | 35.83% | 49.21% | 57.82% | 57.54% | 20.6% | 71.04% | 51.24% | 83.01% | 70.33% |
| Other Operating Expenses | 379K | 1000K | 0 | 896K | 701K | 978K | 769K | 1000K | 1000K | 856K | 1000K | 855K | 674K | 1000K | 923K | 1000K | 688K | 1000K | 870K | 0 |
| Operating Income | -4.7M | -8.55M | 4.45M | 14.09M | 13.51M | -14.31M | -12.51M | -8.72M | -14.94M | 1.37M | -13.04M | -9M | -25.6M | -6.35M | -50.41M | 34.08M | -58.49M | -65.34M | -54.89M | -79.34M |
| Operating Margin % | -8.77% | -14.84% | 7.57% | 22.55% | 23.57% | -30.77% | -33.41% | -19.99% | -45.81% | 2.44% | -31% | -15.96% | -63.98% | -11.51% | -103.47% | 26.97% | -94.8% | -113.28% | -112.57% | -149.95% |
| Operating Income Growth % | -134.75% | 40.22% | 135.58% | 261.48% | 190.48% | -1141.27% | 4.07% | 3.01% | 41.65% | 121.64% | 74.14% | -126.4% | 56.24% | 90.28% | 8.16% | 142.95% | 9.92% | 23.49% | 5.52% | 54.35% |
| EBITDA | -4.37M | -8.23M | 4.77M | 14.4M | 13.83M | -4.96M | -3.13M | 685K | -5.56M | 10.78M | -3.63M | 411K | -16.19M | 3.07M | -40.98M | 43.5M | -49.06M | -55.89M | -45.4M | -70.3M |
| EBITDA Margin % | -8.16% | -14.29% | 8.11% | 23.06% | 24.12% | -10.67% | -8.37% | 1.57% | -17.05% | 19.18% | -8.63% | 0.73% | -40.46% | 5.56% | -84.13% | 34.42% | -79.52% | -96.89% | -93.12% | -132.86% |
| EBITDA Growth % | -131.59% | -65.9% | 252.25% | 2002.92% | 348.66% | -146.04% | 13.72% | 66.67% | 65.65% | 251.19% | 91.14% | -99.06% | 67.01% | 105.49% | 9.74% | 161.88% | 11.45% | 28.06% | 11.8% | 57.18% |
| D&A (Non-Cash Add-back) | 328K | 321K | 318K | 316K | 314K | 9.35M | 9.37M | 9.41M | 9.38M | 9.4M | 9.41M | 9.41M | 9.41M | 9.42M | 9.42M | 9.43M | 9.43M | 9.45M | 9.48M | 9.04M |
| EBIT | -4.7M | -6.41M | 5.9M | 7.08M | 13.88M | -15.93M | -13.38M | -8.22M | -14.29M | 2.03M | -13.08M | -9.53M | -25.32M | 7.78M | -50.14M | 34.49M | -57.36M | -57.42M | -54.46M | -78.08M |
| Net Interest Income | 4.69M | -4.83M | -4.75M | -6.83M | -7.77M | -6.88M | -6.66M | -2.15M | -2.5M | -1.42M | -1.41M | -1.64M | -1.56M | -1.64M | -3.95M | -5.04M | -5.06M | -5.08M | -5.08M | -4.96M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | -4.69M | 4.83M | 4.75M | 6.83M | 7.77M | 6.88M | 6.66M | 2.15M | 2.5M | 1.42M | 1.41M | 1.64M | 1.56M | 1.64M | 3.95M | 5.04M | 5.06M | 5.08M | 5.08M | 4.96M |
| Other Income/Expense | -4.23M | -2.68M | -3.29M | -13.84M | -7.4M | -8.5M | -7.53M | 143K | -3.05M | -760K | -1.45M | -2.18M | -1.28M | -1.2M | -3.69M | -4.63M | -3.93M | -4.52M | -4.66M | -3.7M |
| Pretax Income | -8.93M | -11.23M | 1.16M | 247K | 6.11M | -22.8M | -20.04M | -8.58M | -17.98M | 614K | -14.49M | -11.17M | -26.88M | -7.55M | -54.1M | 29.45M | -62.42M | -69.86M | -59.54M | -83.04M |
| Pretax Margin % | -16.67% | -19.5% | 1.97% | 0.4% | 10.66% | -49.04% | -53.54% | -19.66% | -55.16% | 1.09% | -34.46% | -19.82% | -67.18% | -13.69% | -111.05% | 23.3% | -101.17% | -121.13% | -122.13% | -156.93% |
| Income Tax | 126K | 1.01M | 615K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | -1.41% | -8.98% | 53.25% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -9.05M | -12.24M | 540K | 247K | 6.11M | -22.8M | -20.04M | -8.58M | -17.98M | 614K | -14.49M | -11.17M | -26.88M | -7.55M | -54.1M | 29.45M | -62.42M | -69.86M | -59.54M | -83.04M |
| Net Margin % | -16.91% | -21.25% | 0.92% | 0.4% | 10.66% | -49.04% | -53.54% | -19.66% | -55.16% | 1.09% | -34.46% | -19.82% | -67.18% | -13.69% | -111.05% | 23.3% | -101.17% | -121.13% | -122.13% | -156.93% |
| Net Income Growth % | -248.13% | 46.31% | 102.69% | 102.88% | 133.98% | -3814.01% | -38.3% | 23.18% | 33.08% | 108.13% | 73.22% | -137.94% | 56.94% | 89.19% | 9.15% | 135.46% | 10.29% | 19.7% | 0.69% | 52.75% |
| Net Income (Continuing) | -9.05M | -12.24M | 540K | 247K | 6.11M | -22.8M | -20.04M | -8.58M | -17.98M | 614K | -14.49M | -11.17M | -26.88M | -7.55M | -54.1M | 29.45M | -62.42M | -69.86M | -59.54M | -83.04M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.03 | -0.05 | 0.00 | 0.00 | 0.03 | -0.10 | -0.10 | -0.04 | -0.09 | 0.00 | -0.08 | -0.06 | -0.09 | -0.05 | -0.29 | 0.15 | -0.35 | -0.40 | -0.34 | -0.51 |
| EPS Growth % | -233.99% | 53.9% | 102.1% | 102.25% | 128.11% | - | -23.93% | 33.11% | 0.66% | 106.72% | 73.48% | -139.87% | 74.11% | 88.1% | 14.71% | 129.41% | 22.22% | 33.33% | 19.05% | 60.16% |
| EPS (Basic) | -0.03 | -0.05 | 0.00 | 0.00 | 0.03 | -0.10 | -0.10 | -0.04 | -0.09 | 0.00 | -0.08 | -0.06 | -0.09 | -0.05 | -0.29 | 0.16 | -0.35 | -0.40 | -0.34 | -0.51 |
| Diluted Shares Outstanding | 267.05M | 265.37M | 274.37M | 271.1M | 241.6M | 218.7M | 210.35M | 209.71M | 204.96M | 190.5M | 188.31M | 186.82M | 184.77M | 183.99M | 183.88M | 190.38M | 179.6M | 175.61M | 173.78M | 161.33M |
| Basic Shares Outstanding | 267.05M | 265.37M | 264.79M | 262.57M | 235.5M | 218.7M | 210.35M | 209.71M | 204.96M | 189.9M | 188.31M | 186.82M | 184.77M | 183.99M | 183.88M | 183.6M | 179.6M | 174.65M | 173.78M | 161.33M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |